MARKET

SGMO

SGMO

Sangamo Therapeutics Inc
NASDAQ
0.8649
+0.1929
+28.71%
After Hours: 0.8896 +0.0247 +2.86% 19:59 07/26 EDT
OPEN
0.7133
PREV CLOSE
0.6720
HIGH
1.140
LOW
0.6950
VOLUME
123.71M
TURNOVER
0
52 WEEK HIGH
1.670
52 WEEK LOW
0.2911
MARKET CAP
179.48M
P/E (TTM)
-0.4659
1D
5D
1M
3M
1Y
5Y
1D
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Saia, Inc. Fell 18.6% to $398.01 on Friday. The company reported worse-than-expected second-quarter financial results. BurgerFi International and Windtree Therapeutics were among the stocks moving in today's mid-day session.
Benzinga · 8h ago
Sangamo rallies for third day in wake of positive gene therapy results
Shares of Sangamo rallies for third day in wake of positive gene therapy results. Sangamo (SGMO) shares gained 40% on Wednesday and 20% on Thursday. Pfizer reported positive results for their gene therapy candidate giroctocogene fitelparvovec in the treatment of hemophilia A.
Seeking Alpha · 9h ago
Peering Into Sangamo Therapeutics's Recent Short Interest
Sangamo Therapeutics's short percent of float has fallen 17.95% since its last report. The company has 12.73 million shares sold short, which is 6.17% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 1d ago
Why Is Sangamo Therapeutics (SGMO) Stock Up 40% Today?
Sangamo Therapeutics announced a successful late-stage trial for its drug targeting a rare genetic bleeding disorder. Sangamo stock is up more than 40% on the news. The company is developing the drug in collaboration with Pfizer. The results appear to be promising for Sangamo.
Investorplace · 2d ago
Sangamo Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.
Dow Jones · 2d ago
HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $5 Price Target
Benzinga · 2d ago
Crude Oil Gains 1%; AT&T Shares Rise After Q2 Earnings
U.S. Stocks traded lower on Wednesday. The Dow traded down 0.82%, the NASDAQ fell 2.92% and the S&P 500 fell 1.84%. AT&T Inc. Shares rose 5% after reporting better-than-expected second-quarter earnings. Asian markets closed lower; European shares closed lower today.
Benzinga · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Lamb Weston, Blackstone Mortgage Trust
The Nasdaq plummeted to a one-month low on Wednesday after Tesla and Alphabet disappointed with lackluster earnings. The Dow Jones Industrial Average was down 0.74% and the S&P 500 was down 1.62%. Tesla, Lamb Weston, Blackstone Mortgage Trust were among the biggest losers.
Reuters · 2d ago
More
About SGMO
Sangamo Therapeutics, Inc. is a genomic medicines company that is developing medicines for neurological diseases. The Company's neurology preclinical development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases, and development of novel engineered adeno-associated virus (AAV) capsids to deliver its therapies to the intended neurological targets. The Company's zinc finger epigenetic regulators are ideally suited to potentially address neurological disorders and its capsid discovery platform is expanding delivery beyond intrathecal delivery capsids, including in the central nervous system. Its clinical-stage product candidates are Isaralgagene civaparvovec, also known as ST-920, its wholly-owned gene therapy product candidate for the treatment of Fabry disease, and TX200, its wholly-owned CAR-Treg cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation.

Webull offers Sangamo Therapeutics Inc stock information, including NASDAQ: SGMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGMO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SGMO stock methods without spending real money on the virtual paper trading platform.